BackgroundAging is characterized by anatomical, physiological, and biological changes that can impact drug kinetics. The elderly are often excluded from clinical trials and knowledge about drug kinetics and drug-drug interaction magnitudes is sparse. Physiologically based pharmacokinetic modeling can overcome this clinical limitation but detailed descriptions of the population characteristics are essential to adequately inform models.ObjectiveThe objective of this study was to develop and verify a population database for aging Caucasians considering anatomical, physiological, and biological system parameters required to inform a physiologically based pharmacokinetic model that included population variability.MethodsA structured literature s...
Hepatic clearance plays a key role in determining the systemic exposure of drugs and metabolites, wh...
We present herein a compilation and trend analysis of human i.v. pharmacokinetic data on 670 drugs r...
Purpose of review Population modeling is a relatively new pharmacological discipline, the developmen...
Aging is characterized by anatomical, physiological, and biological changes that can impact drug kin...
BackgroundMedication use is highly prevalent with advanced age, but clinical studies are rarely cond...
Advancing age is characterized by impairment in the function of the many regulatory processes that p...
The goal of most population pharmacokinetic and pharmacodynamic analyses is to develop a model that ...
Some patients are more likely to have drug-induced diseases due to a number of risk factors, such as...
Interindividual variability in anatomical and physiological properties results in significant dif-fe...
265 p.This research project was designed to acquire a deeper knowledge on how physiological changes ...
Age-related changes in anatomy and physiology influence the way drugs are handled by the body. The a...
Although there have been relatively few studies of the pharmacokinetics of antiepileptic drugs (AEDs...
Interindividual variability in anatomical and physiological properties results in significant differ...
We present herein a compilation and trend analysis of human i.v. pharmacokinetic data on 670 drugs r...
People living with HIV (PLWH) are aging but are often excluded from clinical studies because of prag...
Hepatic clearance plays a key role in determining the systemic exposure of drugs and metabolites, wh...
We present herein a compilation and trend analysis of human i.v. pharmacokinetic data on 670 drugs r...
Purpose of review Population modeling is a relatively new pharmacological discipline, the developmen...
Aging is characterized by anatomical, physiological, and biological changes that can impact drug kin...
BackgroundMedication use is highly prevalent with advanced age, but clinical studies are rarely cond...
Advancing age is characterized by impairment in the function of the many regulatory processes that p...
The goal of most population pharmacokinetic and pharmacodynamic analyses is to develop a model that ...
Some patients are more likely to have drug-induced diseases due to a number of risk factors, such as...
Interindividual variability in anatomical and physiological properties results in significant dif-fe...
265 p.This research project was designed to acquire a deeper knowledge on how physiological changes ...
Age-related changes in anatomy and physiology influence the way drugs are handled by the body. The a...
Although there have been relatively few studies of the pharmacokinetics of antiepileptic drugs (AEDs...
Interindividual variability in anatomical and physiological properties results in significant differ...
We present herein a compilation and trend analysis of human i.v. pharmacokinetic data on 670 drugs r...
People living with HIV (PLWH) are aging but are often excluded from clinical studies because of prag...
Hepatic clearance plays a key role in determining the systemic exposure of drugs and metabolites, wh...
We present herein a compilation and trend analysis of human i.v. pharmacokinetic data on 670 drugs r...
Purpose of review Population modeling is a relatively new pharmacological discipline, the developmen...